By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
ICCNICCNICCN
  • Home
  • Conferences
  • Events
  • Media
  • Publications
  • Resources
    • NCCN
    • ASCO
    • Hematology
Reading: ESMO Congress 2025
Sign In
Font ResizerAa
Font ResizerAa
ICCNICCN
  • Home
  • Conferences
  • Events
  • Media
  • Publications
  • Resources
Search
  • Home
  • Conferences
  • Events
  • Media
  • Publications
  • Resources
    • NCCN
    • ASCO
    • Hematology

Trending →

T-DXd Plus Pertuzumab Receives FDA Approval, Shifting the Frontline HER2-Positive Paradigm

By MedOnc2
December 15, 2025

FDA Approves Niraparib Plus Abiraterone Acetate and Prednisone for BRCA2-Mutated mCSPC

By MedOnc2
December 15, 2025

FDA Approves Durvalumab for Resectable Gastric and Gastroesophageal Junction Adenocarcinoma

By MedOnc2
December 15, 2025

FDA Grants Traditional Approval to Pirtobrutinib (Jaypirca®) for CLL/SLL

By MedOnc2
December 15, 2025

Enfortumab Vedotin + Pembrolizumab for Muscle-Invasive Bladder Cancer (MIBC)

By MedOnc2
November 22, 2025
Login Sign In
Follow US
© ICCN All Rights Reserved.
Conferences

ESMO Congress 2025

MedOnc2
Last updated: August 11, 2025 2:38 am
By MedOnc2
Share
1 Min Read
SHARE

The ESMO (European Society for Medical Oncology) Congress 2025 is a major global oncology event taking place in Berlin, Germany, from October 17-21, 2025. It brings together clinicians, researchers, patient advocates, and industry representatives to discuss and showcase the latest advancements in cancer care. The congress will feature groundbreaking discoveries, cutting-edge treatments, and collaborative approaches to shape the future of oncology. 

Focus:

The congress will cover a wide range of topics including cancer prevention, screening, early diagnosis, and the latest breakthroughs in cancer research. 

Key Features:

It will offer opportunities to learn from international experts, engage in discussions, and connect with fellow oncology professionals. 

Target Audience:

The event is relevant for medical/clinical oncologists, basic and translational researchers, oncology nurses, patient advocates, journalists, and industry representatives. 

Location:

The congress will be held in Berlin, Germany, with sessions also accessible through a dedicated online platform

Register:

https://www.esmo.org/meeting-calendar/esmo-congress-2025/registration

Share This Article
Facebook Whatsapp Whatsapp LinkedIn Tumblr Reddit Email Copy Link Print

Recent Posts

  • T-DXd Plus Pertuzumab Receives FDA Approval, Shifting the Frontline HER2-Positive Paradigm
  • FDA Approves Niraparib Plus Abiraterone Acetate and Prednisone for BRCA2-Mutated mCSPC
  • FDA Approves Durvalumab for Resectable Gastric and Gastroesophageal Junction Adenocarcinoma
  • FDA Grants Traditional Approval to Pirtobrutinib (Jaypirca®) for CLL/SLL
  • Enfortumab Vedotin + Pembrolizumab for Muscle-Invasive Bladder Cancer (MIBC)

Recent Comments

No comments to show.

You Might Also Like ↷

ASH 2025 Annual Meeting

August 10, 2025

SOHO 2025 Meeting

August 13, 2025
Interactive Cancer Care Network

Powered By Designjoom-Empowering Brands since 2010